Mayo Clinic Fatty Liver MET Gene Mutation Discovery | AcademicJobs
Mayo Clinic researchers identify rare MET gene mutation as direct cause of fatty liver disease, opening doors to precision diagnostics and therapies.
No reviews yet. Be the first to rate Filippo!
Filippo Pinto e Vairo, M.D., Ph.D., serves as Associate Professor of Medical Genetics at Mayo Clinic. He holds appointments as Associate Consultant II in the Division of Gastroenterology and Hepatology in the Department of Medicine, as well as Associate Consultant II-Research roles in the Department of Pediatrics and the Department of Clinical Genomics at Mayo Clinic Enterprise. Dr. Pinto e Vairo earned his M.D. from the Federal University of Parana, completed a residency in Medical Genetics at Hospital de Clinicas de Porto Alegre, obtained a Master’s degree in Medical Sciences: Medicine and a Ph.D. in Genetics and Molecular Biology from the Federal University of Rio Grande do Sul, and completed a postdoctoral research fellowship at Mayo Clinic.
He is a clinical geneticist whose work centers on lysosomal diseases and precision medicine. His research focuses on developing and implementing novel methodologies to identify genetic variants that cause disease and to functionally validate variant pathogenicity. Dr. Pinto e Vairo is the medical director of the Program for Rare and Undiagnosed Diseases in the Center for Individualized Medicine at Mayo Clinic. In this role, he leads efforts to establish genomic clinical services for patients with rare diseases, improve diagnostic yield through multiomic testing and functional studies, and advance translational research in collaboration with multiple divisions and departments. His contributions support improved clinical management and treatment options for patients with undiagnosed conditions.
Mayo Clinic researchers identify rare MET gene mutation as direct cause of fatty liver disease, opening doors to precision diagnostics and therapies.